-
1
-
-
0028279806
-
Practical Bayesian guidelines for phase IIb clinical trials
-
Thall PF, Simon R. Practical Bayesian guidelines for phase IIb clinical trials. Biometrics 1994; 50:337-349.
-
(1994)
Biometrics
, vol.50
, pp. 337-349
-
-
Thall, P.F.1
Simon, R.2
-
2
-
-
0032885857
-
Decision theoretic designs for phase II clinical trials with multiple outcomes
-
Stallard N, Thall P, Whitehead J. Decision theoretic designs for phase II clinical trials with multiple outcomes. Biometrics 1999; 55:971-977.
-
(1999)
Biometrics
, vol.55
, pp. 971-977
-
-
Stallard, N.1
Thall, P.2
Whitehead, J.3
-
3
-
-
27144518391
-
An optimal sequential design for screening trials
-
Wang Y-G, Leung DH. An optimal sequential design for screening trials. Biometrics 1998; 54:245-252.
-
(1998)
Biometrics
, vol.54
, pp. 245-252
-
-
Wang, Y.-G.1
Leung, D.H.2
-
4
-
-
0035186577
-
Decision-theoretic designs for pre-phase II screening trials in oncology
-
Stallard N, Thall PF. Decision-theoretic designs for pre-phase II screening trials in oncology. Biometrics 2001; 57:1089-1095.
-
(2001)
Biometrics
, vol.57
, pp. 1089-1095
-
-
Stallard, N.1
Thall, P.F.2
-
5
-
-
0038545822
-
Decision-theoretic designs for phase II clinical trials allowing for competing studies
-
Stallard N. Decision-theoretic designs for phase II clinical trials allowing for competing studies. Biometrics 2003; 59:402-409.
-
(2003)
Biometrics
, vol.59
, pp. 402-409
-
-
Stallard, N.1
-
6
-
-
0029071328
-
Bayesian decision procedures for dose determining experiments (disc: P897-899)
-
Whitehead J, Brunier H. Bayesian decision procedures for dose determining experiments (disc: P897-899). Statistics in Medicine 1995; 14:885-893.
-
(1995)
Statistics in Medicine
, vol.14
, pp. 885-893
-
-
Whitehead, J.1
Brunier, H.2
-
7
-
-
0037080851
-
An extension of the continual reassessment method using decision theory
-
Leung D, Wang Y-G. An extension of the continual reassessment method using decision theory. Statistics in Medicine 2002; 21:51-63.
-
(2002)
Statistics in Medicine
, vol.21
, pp. 51-63
-
-
Leung, D.1
Wang, Y.-G.2
-
10
-
-
0001919041
-
Sequential allocation involving several treatments
-
Institute of Mathematical Statistics: Hayward, CA
-
Coad DS. Sequential allocation involving several treatments. Adaptive Designs. Institute of Mathematical Statistics: Hayward, CA, 1995; 95-105.
-
(1995)
Adaptive Designs
, pp. 95-105
-
-
Coad, D.S.1
-
11
-
-
0035106433
-
A Bayesian decision approach for sample size determination in Phase II trials
-
Leung DH, Wang YG. A Bayesian decision approach for sample size determination in Phase II trials. Biometrics 2001; 57:309-312.
-
(2001)
Biometrics
, vol.57
, pp. 309-312
-
-
Leung, D.H.1
Wang, Y.G.2
-
13
-
-
0025148278
-
Continual reassessment method: A practical design for Phase 1 clinical trials in cancer
-
O'Quigley J, Pepe M, Fisher L. Continual reassessment method: a practical design for Phase 1 clinical trials in cancer. Biometrics 1990; 46:33-48.
-
(1990)
Biometrics
, vol.46
, pp. 33-48
-
-
O'Quigley, J.1
Pepe, M.2
Fisher, L.3
-
14
-
-
0036277621
-
The bivariate continual reassessment method: Extending the CRM to phase I trials of two competing outcomes
-
Braun T. The bivariate continual reassessment method: extending the CRM to phase I trials of two competing outcomes. Controlled Clinical Trial 2002; 23:240-256.
-
(2002)
Controlled Clinical Trial
, vol.23
, pp. 240-256
-
-
Braun, T.1
-
17
-
-
0018767566
-
Stoppable families of alternative bandit processes
-
Glazebrook KD. Stoppable families of alternative bandit processes. Journal of Applied Probability 1979; 16: 843-854.
-
(1979)
Journal of Applied Probability
, vol.16
, pp. 843-854
-
-
Glazebrook, K.D.1
-
19
-
-
0032887598
-
Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials
-
Thall PF, Cheng S. Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials. Biometrics 1999; 55:746-753.
-
(1999)
Biometrics
, vol.55
, pp. 746-753
-
-
Thall, P.F.1
Cheng, S.2
-
20
-
-
0031953966
-
A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trial
-
Thall PF, Russell K. A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trial. Biometrics 1998; 54:251-264.
-
(1998)
Biometrics
, vol.54
, pp. 251-264
-
-
Thall, P.F.1
Russell, K.2
-
21
-
-
33746402001
-
Consistency of continual reassessment method under model misspecification
-
Shen LZ, O'Quigley J. Consistency of continual reassessment method under model misspecification. Biometrika 1996; 83:395-405.
-
(1996)
Biometrika
, vol.83
, pp. 395-405
-
-
Shen, L.Z.1
O'Quigley, J.2
|